Wart treatment
Patent 5006338 Issued on April 9, 1991. Estimated Expiration Date: 
April 9, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
April 9, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 104146 203965 InventorApplicationNo. 156628 filed on 02/17/1988US Classes:424/742, Containing or obtained from Eucalypti (e.g., eucalyptus, etc.)424/714, Plant extract of undetermined constitution514/885IMMUNE RESPONSE AFFECTING DRUGExaminersPrimary: Rollins, John W.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 035/78A61K 033/04 Foreign Application Priority Data1987-02-18 DEAbstractA wart treatment consists of a perorally administrable mixture of liquid dilutions (degree of dilution D2 to D6) of known phytopreparations which individually and/or collectively exhibit an immunostimulating effect. Preferably, at least a content of (a) 0.5 to 2 parts by weight of Euphorbia cyparissias, degree of dilution D3 to D6; (b) 0.5 to 2 parts by weight of Clematis recta, degree of dilution D2 to D4; and (c) 0.5 to 2 parts by weight of Mezereum, degree of dilution D2 to D4 is provided. In addition, one or several component(s) of the following group may selectively be provided, viz. (d) Ranunculus, degree of dilution D2 to D4; (e) Veratrum album, degree of dilution D3 to D6; (f) Aconitum, degree of dilution D3 to D6; (g) Arnica, degree of dilution D2 to D4; (h) Atropa belladonna, degree of dilution D3 to D6; (i) Cinchona succiruba (China), degree of dilution D2 to D4; (k) Eucalyptus globulus, degree of dilution D2 to D4; (l) Lycopodium, degree of dilution D3 to D6; Nux vomica, degree of dilution D3 to D6; and (n) sulfur, degree of dilution D4 to D6. The treatment is effective by stimulating the endogenous immunodefense mechanisms, wherein a controlled reaction against papillomaviruses is provoked.Other References
| |
